Form D Explorer
Paralos Bioscience Inc. · CIK 2080259

Report a data issueCitable research briefCompare issuerPrivate research collection

Paralos Bioscience Inc.

CIK 2080259 · Corporation · Inc. DELAWARE · LOS ANGELES, California · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filing history at a glance

The reported amount sold was $328,900 in the Apr 17, 2026 filing and $646,900 in the Jun 23, 2026 filing. The two records may concern different offerings. Amendments account for 3 of the 4 filings stored from Aug 7, 2025 to Jun 23, 2026.

Filings
4
Original notices
1
Amendments
3
Activity
Aug 7, 2025
through Jun 23, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldApr 17, 2026 · D/AJun 23, 2026 · D/ALater minus earlier
Reported offering amount$1,000,000$1,000,000$0
Reported amount sold$328,900$646,900$318,000
Reported investor count—5—
Reported minimum investment$5,000$5,000$0

Earlier SEC source: 0002080259-26-000001 · Later SEC source: 0002080259-26-000002

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Jun 23, 2026

Reported offering amount
$1,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$646,900

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (4)